Edition:
United States

Arcadia Biosciences Inc (RKDA.OQ)

RKDA.OQ on NASDAQ Stock Exchange Capital Market

0.19USD
2:00pm EST
Change (% chg)

$-0.02 (-8.33%)
Prev Close
$0.21
Open
$0.22
Day's High
$0.22
Day's Low
$0.18
Volume
77,198
Avg. Vol
49,709
52-wk High
$1.50
52-wk Low
$0.18

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -0.10 December 12 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 3.00 3.00 3.00 3.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 1 0.80 0.80 0.80 1.60
Quarter Ending Mar-18 1 1.70 1.70 1.70 11.20
Year Ending Dec-17 1 3.40 3.40 3.40 6.70
Year Ending Dec-18 1 8.30 8.30 8.30 45.00
Earnings (per share)
Quarter Ending Dec-17 1 -0.10 -0.10 -0.10 -0.07
Quarter Ending Mar-18 1 -0.07 -0.07 -0.07 0.03
Year Ending Dec-17 1 -0.40 -0.40 -0.40 -0.30
Year Ending Dec-18 1 -0.24 -0.24 -0.24 0.14

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 1.00 0.59 0.41 41.10
Quarter Ending Jun-17 1.30 0.99 0.31 23.77
Quarter Ending Mar-17 1.20 1.02 0.18 15.17
Quarter Ending Dec-16 1.00 0.54 0.46 46.00
Quarter Ending Sep-16 2.10 1.08 1.02 48.81

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 0.80 0.80 0.90 0.90 1.60
Quarter Ending Mar-18 1.70 1.70 3.40 3.40 11.20
Year Ending Dec-17 3.40 3.40 3.90 3.90 6.70
Year Ending Dec-18 8.30 8.30 14.60 14.60 45.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 0 1
Quarter Ending Mar-18 0 0 0 1
Year Ending Dec-17 0 0 0 1
Year Ending Dec-18 0 0 0 1
Earnings